Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $16.55 and traded as high as $18.43. Kewaunee Scientific shares last traded at $18.06, with a volume of 187 shares changing hands.
Wall Street Analyst Weigh In
Separately, TheStreet upgraded Kewaunee Scientific from a “c+” rating to a “b-” rating in a research report on Thursday, August 31st.
Kewaunee Scientific Price Performance
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last announced its quarterly earnings data on Thursday, August 31st. The technology company reported $0.86 earnings per share (EPS) for the quarter. The company had revenue of $49.84 million during the quarter. Kewaunee Scientific had a net margin of 1.81% and a return on equity of 10.53%.
In other news, VP Elizabeth D. Phillips sold 1,557 shares of the company’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $17.56, for a total value of $27,340.92. Following the transaction, the vice president now owns 14,035 shares of the company’s stock, valued at approximately $246,454.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 14.50% of the company’s stock.
Hedge Funds Weigh In On Kewaunee Scientific
Institutional investors have recently modified their holdings of the business. BlackRock Inc. grew its stake in Kewaunee Scientific by 58.2% during the 2nd quarter. BlackRock Inc. now owns 13,102 shares of the technology company’s stock worth $198,000 after purchasing an additional 4,822 shares in the last quarter. Minerva Advisors LLC grew its position in shares of Kewaunee Scientific by 1.4% during the first quarter. Minerva Advisors LLC now owns 172,919 shares of the technology company’s stock worth $2,730,000 after buying an additional 2,378 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Kewaunee Scientific by 1.3% during the first quarter. Vanguard Group Inc. now owns 126,581 shares of the technology company’s stock worth $1,836,000 after buying an additional 1,683 shares during the period. Dimensional Fund Advisors LP lifted its stake in Kewaunee Scientific by 0.4% in the third quarter. Dimensional Fund Advisors LP now owns 185,989 shares of the technology company’s stock worth $3,273,000 after acquiring an additional 742 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Kewaunee Scientific by 0.7% during the 2nd quarter. Renaissance Technologies LLC now owns 98,111 shares of the technology company’s stock worth $1,631,000 after acquiring an additional 700 shares in the last quarter. Institutional investors and hedge funds own 32.98% of the company’s stock.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
- Five stocks we like better than Kewaunee Scientific
- Overbought Stocks Explained: Should You Trade Them?
- 3 large caps with red hot RSIs with upside
- What is a Mid Cap Stock? How to Invest
- Johnson Controls International: Nothing but upside for investors
- Trading Halts Explained
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.